Contact Us News RSS Login

Harvard Catalyst - The Harvard Clinical and Translational Science Center
  1. People
    1. Overview
    2. Grant Central
    3. Medvane
    4. Profiles
  2. Learning
    1. Overview
    2. Colloquium Series
    3. Conferences and Seminars
    4. Dean's Symposium
    5. Leder Human Biology
    6. Biomedical Informatics Training
    7. Biostatistics Training
    8. Clinical Investigator Training Program
    9. Scholars in Clinical Science
    10. KL2 Medical Research Investigator Training
    11. Introduction to Clinical Investigation
    12. Biostatistics Seminar Series
    13. Genetics Courses
    14. Imaging Courses
  3. Resources
    1. Overview
    2. Pilot Funding
    3. AEGIS Influenza
    4. Atlas
    5. Community-Based Participatory Research
    6. Community Connect to Research
    7. Consulting Programs
    8. Core Facilities
    9. HarvardTrials
    10. Health Disparities Research Program
    11. In/Outpatient Resources
    12. Laboratory for Innovative Translational Technologies
    13. Law and Health Policy
    14. Medications and Society
    15. Pathology Specimen Locator
    16. SHRINE
    17. Webdash
Find
People

Profiles

Read About Profiles -- the Harvard Catalyst's social networking site.
Find information about people's institutions in the Atlas.

Jeffrey T. Yap, PH.D.

  Back
Title
Assistant Professor of Radiology
Institution
Dana-Farber Cancer Institute
Department
Radiology
Address
Dana Farber Cancer Institute
Division of Nuclear Medicine
44 Binney St
Boston, MA 02115
Email
Email Address
Publications
1. Kao CM, Yap JT, Mukherjee J, Wernick MN. Image reconstruction for dynamic PET based on low-order approximation and restoration of the sinogram. IEEE Trans Med Imaging. 1997 Dec; 16(6):738-49.
2. Kaufmann PA, Gnecchi-Ruscone T, Yap JT, Rimoldi O, Camici PG. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. J Nucl Med. 1999 Nov; 40(11):1848-56.
3. Gunn RN, Ranicar A, Yap JT, Wells P, Osman S, Jones T, Cunningham VJ. On-line measurement of exhaled [11C]CO2 during PET. J Nucl Med. 2000 Apr; 41(4):605-11.
4. Gunn RN, Yap JT, Wells P, Osman S, Price P, Jones T, Cunningham VJ. A general method to correct PET data for tissue metabolites using a dual-scan approach. J Nucl Med. 2000 Apr; 41(4):706-11.
5. Saleem A, Yap J, Osman S, Brady F, Suttle B, Lucas SV, Jones T, Price PM, Aboagye EO. Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action. Lancet. 2000 Jun 17; 355(9221):2125-31.
6. Anderson HL, Yap JT, Miller MP, Robbins A, Jones T, Price PM. Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate. J Clin Oncol. 2003 Aug 1; 21(15):2823-30.
7. Anderson H, Yap JT, Wells P, Miller MP, Propper D, Price P, Harris AL. Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane. Br J Cancer. 2003 Jul 21; 89(2):262-7.
8. Townsend DW, Carney JP, Yap JT, Hall NC. PET/CT today and tomorrow. J Nucl Med. 2004 Jan; 45 Suppl 1:4S-14S.
9. Yap JT, Carney JP, Hall NC, Townsend DW. Image-guided cancer therapy using PET/CT. Cancer J. 2004 Jul-Aug; 10(4):221-33.
10. Shankar LK, Hoffman JM, Bacharach S, Graham MM, Karp J, Lammertsma AA, Larson S, Mankoff DA, Siegel BA, Van den Abbeele A, Yap J, Sullivan D. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med. 2006 Jun; 47(6):1059-66.
11. Wall JS, Kennel SJ, Paulus M, Gregor J, Richey T, Avenell J, Yap J, Townsend D, Weiss DT, Solomon A. Radioimaging of light chain amyloid with a fibril-reactive monoclonal antibody. J Nucl Med. 2006 Dec; 47(12):2016-24.
12. Masciari S, Van den Abbeele AD, Diller LR, Rastarhuyeva I, Yap J, Schneider K, Digianni L, Li FP, Fraumeni JF, Syngal S, Garber JE. F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA. 2008 Mar 19; 299(11):1315-9.
13. Raje N, Woo SB, Hande K, Yap JT, Richardson PG, Vallet S, Treister N, Hideshima T, Sheehy N, Chhetri S, Connell B, Xie W, Tai YT, Szot-Barnes A, Tian M, Schlossman RL, Weller E, Munshi NC, Van Den Abbeele AD, Anderson KC. Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw. Clin Cancer Res. 2008 Apr 15; 14(8):2387-95.
14. Shankar LK, Van den Abbeele A, Yap J, Benjamin R, Scheutze S, Fitzgerald TJ. Considerations for the use of imaging tools for phase II treatment trials in oncology. Clin Cancer Res. 2009 Mar 15; 15(6):1891-7.
15. George S, Merriam P, Maki RG, Van den Abbeele AD, Yap JT, Akhurst T, Harmon DC, Bhuchar G, O'Mara MM, D'Adamo DR, Morgan J, Schwartz GK, Wagner AJ, Butrynski JE, Demetri GD, Keohan ML. Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas. J Clin Oncol. 2009 Jul 1; 27(19):3154-60.
16. Otero HJ, Yap JT, Patak MA, Erturk SM, Israel DA, Johnston CJ, Sakellis C, Rybicki FJ, Van den Abbeele AD, Ros PR. Evaluation of low-density neutral oral contrast material in PET/CT for tumor imaging: results of a randomized clinical trial. AJR Am J Roentgenol. 2009 Aug; 193(2):326-32.
 
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.